Your search for major depressive disorder returned 36 results

Electronic health records from 77 health care organizations in the US were evaluated for a risk for endocarditis among patients with opioid use disorder or cocaine use disorder on the basis of contracting COVID-19.

Investigators from the Veteran’s Affairs Center for Innovation to Implementation and Stanford University searched publication databases through June 2022 for observational studies about methamphetamine-associated heart failure.

Investigators looked into which treatment fared better for patients with anxiety disorders: a mindfulness-based stress reduction intervention or escitalopram.

Researchers measured associations between trauma and child psychiatric disorders in a birth cohort in Brazil.

Researchers assessed characteristics and correlates of metabolic syndrome in adolescents with major depressive disorder or bipolar disorder depression.

Researchers examined associations between polygenic risk scores and neuropsychiatric conditions using data from phenome-wide association studies.

Researchers compared the white matter networks of patients with remitted major depressive disorder and remitted bipolar disorder to find disease-specific alterations.

Researchers evaluated the efficacy of dextromorphan-bupropion among patients with major depressive disorder and comorbid anxiety.

Researchers investigated whether lurasidone monotherapy would improve health-related quality of life.

Researchers investigated whether there were identifiable treatment-specific and shared predictors for response to pharmacotherapies for ADHD among children.

Researchers investigated whether individuals with symptoms of depression were more sensitive to missed opportunities.

Researchers searched for protective effects in gut microbiota from the pathogenesis of major depressive disorder.

Researchers investigated whether earlier initiation of paliperidone palmitate was associated with fewer events of treatment failure due to hospitalization, arrest, or incarceration compared with oral antipsychotics among patients with schizophrenia.

Pregnant women with a psychiatric disorder or receiving psychiatric medications were recruited to test the efficacy of online cognitive behavioral therapy to manage stress during the COVID-19 pandemic.

A cross-sectional family study sought to determine if parents’ transmission of anxiety is sex specific.

The researchers sought to examine whether inflammation and white matter microstructure play a role in treatment response in major depressive disorder.

Outpatients were recruited at the Instituto Nacional de Psiquiatía (National Institute of Psychiatry) in Mexico and were evaluated for alcohol dependence and major depressive disorder.

For this study, community-dwelling adults were evaluated for major depressive disorder, generalized anxiety disorder, and global sleep quality over an 18 year period.

Pediatric patients with autism spectrum disorder were recruited at 41 sites in the United States for the aV1ation study between 2016 and 2019.

Investigators sourced data from the Norwegian Mother, Father and Child Cohort Study which was a population-based pregnancy cohort study conducted between 1999 and 2008.

Inpatients with persistent depressive disorder were recruited at a German University Hospital for a 10-week inpatient treatment with the Cognitive Behavioral Analysis System of Psychotherapy.

This observational study was conducted by telephone interviews between April and July 2020.

The Cantabria Early Intervention in Psychosis Program (PAFIP) was conducted between 2012 and 2018 in Spain.

Patients with somatoform disorders, major depressive disorder, and healthy controls were recruited between 2016 and 2017 at the Ambulante Psychosoziale Rehabilitation in Austria and Schoen Clinic Roseneck in Germany.

For this study, patients with generalized anxiety disorder were recruited from the Nanfang Hospital in China between 2018 and 2020.

In a randomized clinical trial, researchers observed the efficacy of escitalopram compared with exercise training and placebo in reducing anxiety in patients with CHD.

This prospective, multi-center, open-label trial, CAN-BIND-1 was conducted between 2012 and 2017.

Previous studies have found that perinatal women have had detriments to sleep and depression during the pandemic; however, all studies to date in the perinatal setting have lacked a comparator group, so robust conclusions about the effect of the COVID-19 pandemic have not been elucidated.

Data for this study were sourced from 4 active treatment arms of 4 randomized, controlled trials conducted by the National Institutes of Health in the United States between 2006 and 2018.

Patients with treatment-resistant major depressive disorder or bipolar disorder without psychotic symptoms received intravenous infusions of 0.5 mg/kg ketamine 3 times per week for 2 weeks.